Literature DB >> 24643215

Use of treatment information from a state central cancer registry in prostate cancer research.

Hong Xiao, Fei Tan, Pierre Goovaerts, Georges Adunlin, Askal Ayalew Ali, Clement K Gwede, Youjie Huang.   

Abstract

A method was developed to categorize prostate cancer treatments for epidemiologic and outcomes studies. A total of 60,497 prostate cancer cases from the Florida Cancer Data System diagnosed between 2001 and 2007 were used. The classification has the following properties. First, the treatments classified in the same group are clinically comparable and capture all prostate cancer treatments or combinations of treatments (exhaustive classification). Second, the grouping was set up in a way that each patient is captured in only 1 treatment category without leaving out any patient due to treatment type (mutually exclusive categories). The prostate cancer cases were initially categorized into 14 combinations of treatment, which were then collapsed into 8 broader groups in order to maintain a large sample size for all groups, with treatments remaining clinically comparable within a group.

Entities:  

Mesh:

Year:  2013        PMID: 24643215      PMCID: PMC4341820     

Source DB:  PubMed          Journal:  J Registry Manag        ISSN: 1945-6131


  15 in total

Review 1.  The evolution of the population-based cancer registry.

Authors:  Donald M Parkin
Journal:  Nat Rev Cancer       Date:  2006-08       Impact factor: 60.716

2.  Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.

Authors:  Jason C Massengill; Leon Sun; Judd W Moul; Hongyu Wu; David G McLeod; Christopher Amling; Raymond Lance; John Foley; Wade Sexton; Leo Kusuda; Andrew Chung; Douglas Soderdahl; Timothy Donahue
Journal:  J Urol       Date:  2003-05       Impact factor: 7.450

3.  Impact of age at diagnosis on prostate cancer treatment and survival.

Authors:  Seth K Bechis; Peter R Carroll; Matthew R Cooperberg
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

4.  Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials.

Authors:  R Valicenti; J Lu; M Pilepich; S Asbell; D Grignon
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

5.  Validity of cancer registry data for measuring the quality of breast cancer care.

Authors:  Jennifer L Malin; Katherine L Kahn; John Adams; Lorna Kwan; Marianne Laouri; Patricia A Ganz
Journal:  J Natl Cancer Inst       Date:  2002-06-05       Impact factor: 13.506

6.  Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.

Authors:  J E Fowler; S A Bigler; G Bowman; N K Kilambi
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

7.  Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.

Authors:  F J Fowler; M McNaughton Collins; P C Albertsen; A Zietman; D B Elliott; M J Barry
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

Review 8.  Active surveillance for prostate cancer: a systematic review of the literature.

Authors:  Marc A Dall'Era; Peter C Albertsen; Christopher Bangma; Peter R Carroll; H Ballentine Carter; Matthew R Cooperberg; Stephen J Freedland; Laurence H Klotz; Christopher Parker; Mark S Soloway
Journal:  Eur Urol       Date:  2012-06-07       Impact factor: 20.096

9.  Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.

Authors:  Rebecka Arnsrud Godtman; Erik Holmberg; Ali Khatami; Johan Stranne; Jonas Hugosson
Journal:  Eur Urol       Date:  2012-09-05       Impact factor: 20.096

10.  A case of definitive therapy for localised prostate cancer: report of a urological nightmare.

Authors:  Andreas Sommerhuber; Verena Traxlmayr; Wolfgang Loidl
Journal:  Adv Urol       Date:  2011-09-15
View more
  1 in total

1.  Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Askal Ali; Georges Adunlin; Clement K Gwede; Youjie Huang
Journal:  Am J Mens Health       Date:  2013-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.